Avenue Therapeutics Inc. (ATXI)
NASDAQ · Healthcare
Avenue Therapeutics Inc. Operating Income 2024–2025
Avenue Therapeutics Inc. annual/quarterly operating income history and growth rate from 2024 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Avenue Therapeutics Inc. operating income for the quarter ending September 30, 2025 was -724000, a 77.06% decrease year-over-year.
- Avenue Therapeutics Inc. operating income for the twelve months ending September 30, 2025 was -6.4 M.
- Avenue Therapeutics Inc. annual operating income for 2025 was -3.1 M, a 72.68% decrease from 2024.
- Avenue Therapeutics Inc. annual operating income for 2024 was -11.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Avenue Therapeutics Inc. Operating Income — FAQ
Avenue Therapeutics Inc. (ATXI) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Avenue Therapeutics Inc.'s operating income?
Avenue Therapeutics Inc. (ATXI) reported operating income of -$3M for fiscal 2025.
Where can I see ATXI's operating income history?
The chart and table above show Avenue Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.